In another cohort including 987 patients with ER+/HER2− breast tumors receiving adjuvant chemotherapy, high TILs were associated with better DDFS, and high Ki-67 expression remained significantly associated with TILs in a multivariate regression analysis (26). This evidence concerns the gene MKI67 and breast neoplasm.